Toxicity and efficacy gemtuzumab ozogamicin with chemotherapy in patients with relapses or refractory acute myeloid leukemia

Autor:	Bella Ayubova, Bondarenko, S. N., Uspenskaya, O. S., Karyagina, E. V., Darskaya, E. I., Samorodova, I. A., Smirnova, A. G., Pirogova, O. V., Babenko, E. V., Barkhatov, I. M., Gindina, T. L., Moiseev, I. S., Kulagin, A. D., Afanasyev, B. V.
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1fa1a64c8ea9c3abcce9ed433f1e40b4 http://www.scopus.com/inward/record.url?eid=2-s2.0-85076796392&partnerID=MN8TOARS Zobrazit plný text záznamu